Zentalis Pharmaceuticals, Inc. (ZNTL)
1.36
-0.13
(-8.72%)
USD |
NASDAQ |
Nov 18, 16:00
1.36
0.00 (0.00%)
After-Hours: 20:00
Zentalis Pharmaceuticals Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2024 | -176.7% |
| September 30, 2024 |
| Date | Value |
|---|---|
| June 30, 2024 | |
| March 31, 2024 | 24.75% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ARS Pharmaceuticals, Inc. | -94.37% |
| ACADIA Pharmaceuticals, Inc. | 15.64% |
| Alnylam Pharmaceuticals, Inc. | -- |
| Anika Therapeutics, Inc. | -1.02% |
| Savara, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -70.81% |
| Return on Assets | -52.28% |
| Return on Invested Capital | -59.36% |
| Return on Net Operating Assets | -452.2% |